Literature DB >> 13905172

Antigenic studies of Candida. III. Comparative pathogenicity of Candida albicans group A, group B, and Candida stellatoidea.

H F HASENCLEVER, W O MITCHELL.   

Abstract

Hasenclever, H. F. (U. S. Public Health Service, Bethesda, Md.), and William O. Mitchell. Antigenic studies of Candida. III. Comparative pathogenicity of Candida albicans group A, group B, and Candida stellatoidea. J. Bacteriol. 82:578-581. 1961.-Since the antigenic differences between Candida albicans group A and C. albicans group B had been established, the problem of a difference in pathogenicity for laboratory animals was studied. Candida stellatoidea was also included in this investigation. Similar experiments with Candida tropicalis have been reported. The virulence of 24 strains of C. albicans group A, 23 strains of C. albicans group B, and 11 strains of C. stellatoidea for mice was determined. Five C. albicans group B and four C. stellatoidea strains were tested for lethality in rabbits.C. albicans group A and C. albicans group B displayed about the same degree of virulence for mice. Although C. stellatoidea in general showed less virulence for mice than C. albicans, some of its strains were more virulent than the least virulent C. albicans strains. All five C. albicans group B strains tested in rabbits demonstrated considerably more virulence for this laboratory animal than any of the four C. stellatoidea strains tested.C. albicans group B was isolated from more diverse clinical specimens than C. albicans group A, but only a small number of specimens were studied.

Entities:  

Keywords:  CANDIDA/immunology

Mesh:

Year:  1961        PMID: 13905172      PMCID: PMC279211          DOI: 10.1128/jb.82.4.578-581.1961

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  4 in total

1.  Comparative pathogenicity of Candida albicans for mice and rabbits.

Authors:  H F HASENCLEVER
Journal:  J Bacteriol       Date:  1959-07       Impact factor: 3.490

2.  Pathogenicity of C. albicans and C. tropicalis.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  Sabouraudia       Date:  1961-01

3.  The experimental pathogenicity of various species of Candida in Swiss mice.

Authors:  Z T MANKOWSKI
Journal:  Trans N Y Acad Sci       Date:  1957-04

4.  Antigenic studies of Candida. II. Antigenic relation of Candida albicans group A and group B to Candida stellatoidea and Candida tropicalis.

Authors:  H F HASENCLEVER; W O MITCHELL; J LOEWE
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

  4 in total
  21 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade.

Authors:  Claude Pujol; Michael Pfaller; David R Soll
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

3.  THE INCIDENCE OF THE SEROLOGICAL GROUPS OF CANDIDA ALBICANS IN SOUTHERN ENGLAND.

Authors:  F C STALLYBRASS
Journal:  J Hyg (Lond)       Date:  1964-09

4.  [SEROLOGICAL STRUCTURE: SOME CONSIDERATIONS ON CERTAIN SPECIES OF THE GENUS CANDIDA].

Authors:  R C ARTAGAVEYTIA-ALLENDE
Journal:  Mycopathol Mycol Appl       Date:  1963-08-31

Review 5.  Candida albicans strain delineation.

Authors:  W G Merz
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

6.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

7.  Comparison between methods for serotyping of Candida albicans produces discrepancies in results.

Authors:  D L Brawner
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

8.  Identification of Candida isolated from the cutaneous candidiasis by the combined use of confirmatory medium and slide agglutination with monofactorial antibodies.

Authors:  T Nishikawa; S Harada; H Hatano; Y Fukazawa; T Tsuchiya
Journal:  Mycopathol Mycol Appl       Date:  1971-03-25

Review 9.  [The genus Candida: some notes on its current state].

Authors:  R C Artagaveytia-Allende
Journal:  Mycopathol Mycol Appl       Date:  1965-04-14

10.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.